Lineage Cell Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.About LCTX
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.
CEOBrian M. Culley
CEOBrian M. Culley
Employees75
Employees75
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded1990
Founded1990
Employees75
Employees75
LCTX Key Statistics
Market cap209.24M
Market cap209.24M
Price-Earnings ratio-8.82
Price-Earnings ratio-8.82
Dividend yield—
Dividend yield—
Average volume931.40K
Average volume931.40K
High today$1.11
High today$1.11
Low today$1.10
Low today$1.10
Open price$1.11
Open price$1.11
Volume58.25K
Volume58.25K
52 Week high$1.61
52 Week high$1.61
52 Week low$0.8414
52 Week low$0.8414
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%